Dornan David 4
4 · Elevation Oncology, Inc. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Dornan David
CHIEF SCIENTIFIC OFFICER
Transactions
- Tax Payment
Common Stock
2025-02-15$0.67/sh−4,152$2,789→ 5,223 total - Exercise/Conversion
Restricted Stock Unit
2025-02-15−9,375→ 28,125 total→ Common Stock (9,375 underlying) - Exercise/Conversion
Common Stock
2025-02-15+9,375→ 9,375 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]25% of the RSUs vested on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F3]The RSUs do not expire; they either vest or are canceled prior to the vesting date.